Nomura Asset Management CO LTD Ventyx Biosciences, Inc. Transaction History

Nomura Asset Management CO LTD

10 transactions

Quarter	Operation	Price Per share
Q3 2023 Nov 03, 2023	BUY	$29.8 - $40.3 $0 - $0
Q2 2023 Aug 14, 2023	BUY	$28.53 - $39.55 $0 - $0
Q1 2023 Jan 10, 2025	BUY	$29.51 - $46.65 $0 - $0
Q1 2023 May 11, 2023	BUY	$29.51 - $46.65 $0 - $0
Q4 2022 Jan 10, 2025	BUY	$24.16 - $36.38 $0 - $0
Q4 2022 Feb 14, 2023	BUY	$24.16 - $36.38 $0 - $0
Q3 2022 Jan 10, 2025	BUY	$12.64 - $38.7 $0 - $0
Q3 2022 Nov 14, 2022	BUY	$12.64 - $38.7 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$12.64 - $38.7 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$12.64 - $38.7 $0 - $0

134

55.2M

81.4K

148K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $69.5M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.